Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Montichiari

8 clinical trials in Montichiari, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Montichiari at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Montichiari

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Frexalimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Insulin Glargine
  • Sponsor:Novo Nordisk A/S
Investigational
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Obexelimab
  • Sponsor:Zenas Biopharma (USA) LLC
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:ADC Therapeutics SA
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Charcoal, Activated
  • Sponsor:Novartis Pharma AG
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Dimethyl Fumarate
  • Sponsor:Novartis Pharma AG
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Montichiari

What the registry says about research in the country

01 Multiple Sclerosis Research

Innovative clinical trials focusing on relapsing multiple sclerosis (RMS) treatment options, evaluating novel therapeutic approaches for improved patient outcomes.

  • Long-term safety evaluations of established treatments
  • Comparison studies of new therapeutic agents
  • Treatment options for newly diagnosed patients

Multiple ongoing studies examining various treatment modalities and their effectiveness in managing MS symptoms and disease progression.

02 Lymphoma Studies

Advanced research into Diffuse Large B-Cell Lymphoma (DLBCL), investigating combination therapies and immunochemotherapy approaches.

  • Novel antibody-based treatments
  • Combination therapy evaluations
  • Treatment strategies for refractory cases

Focusing on developing more effective treatment options for patients with resistant or recurring lymphoma.

03 Diabetes Management

Comprehensive studies examining new approaches for Type 2 Diabetes management, particularly in overweight patients requiring insulin therapy.

  • Insulin optimization strategies
  • Combined treatment approaches
  • Weight management considerations

Investigating innovative treatment combinations to improve glycemic control while optimizing insulin dosing.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.